Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer

Condition:   Prostate CancerInterventions:   Other: Brachytherapy + Decapeptyl® SR 22.5mg Triptorelin;   Radiation: BrachytherapySponsor:   IpsenActive, not recruiting - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials